Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1

In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...
News Medical

Synthetic mucin gels against HIV-1 and HSV-2 transmission

In a recent study published in the Advanced Science journal, researchers assessed the effectiveness of synthetic mucin gels in the inhibition of human immunodeficiency virus-1 (HIV-1) and herpes ...
Newsday

HIV Prevention Drug Truvada Might Lower Genital Herpes Risk, Too

A combination drug used to treat and prevent HIV -- Truvada -- may have an additional benefit: lowering the risk of a genital herpes infection, a new study suggests. Researchers found that African ...
Infectious Disease Advisor

Pritelivir Shows Efficacy for Refractory HSV in Immunocompromised Patients

A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.
News Medical

Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus

A group of researchers led by Xavier Saelens and Sven Eyckerman at the VIB-UGent Center for Medical Biotechnology discovered how a protein linked to the human immune system wards off HIV-1 and herpes ...
JSTOR Daily

Clinical and Virologic Response to Episodic Acyclovir for Genital Ulcers Among HIV-1 Seronegative, Herpes Simplex Virus Type 2 Seropositive African Women: A Randomized, Placebo ...

Jared M. Baeten, Stewart E. Reid, Sinead Delany-Moretlwe, James P. Hughes, Richard S. Wang, Ellen Wilcox, Mohammed Limbada, Godspower Akpomiemie, Lawrence Corey, Anna Wald and Connie Celum In a ...